The expression and prognostic value of protein tyrosine kinase 6 in early-stage cervical squamous cell cancer

par Wang, Xiao-Jing, Xiong, Ying, Ma, Ze-Biao, Xia, Jian-Chuan, Li, Yan-Fang
Publié dans Chin J Cancer (2016)

Promise of cancer stem cell vaccine

par Zhou, Li, Lu, Lin, Wicha, Max S, Chang, Alfred E, Xia, Jian-chuan, Ren, Xiubao, Li, Qiao
Publié dans Hum Vaccin Immunother (2015)

Complications of high intensity focused ultrasound in patients with recurrent and metastatic abdominal tumors

par Li, Jian-Jun, Xu, Guo-Liang, Gu, Mo-Fa, Luo, Guang-Yu, Rong, Zhang, Wu, Pei-Hong, Xia, Jian-Chuan
Publié 2007

Pooled safety analyses of ALK-TKI inhibitor in ALK-positive NSCLC

par Zhu, Qian, Hu, Hao, Weng, De-Sheng, Zhang, Xiao-Fei, Chen, Chang-Long, Zhou, Zi-Qi, Tang, Yan, Xia, Jian-Chuan
Publié dans BMC Cancer (2017)

IL-37 induces anti-tumor immunity by indirectly promoting dendritic cell recruitment and activation in hepatocellular carcinoma

par Liu, Yuan, Zhao, Jing-Jing, Zhou, Zi-Qi, Pan, Qiu-Zhong, Zhu, Qian, Tang, Yan, Xia, Jian-Chuan, Weng, De-Sheng
Publié dans Cancer Manag Res (2019)

The Roles of Ubiquitination Factor E4B (UBE4B) in the Postoperative Prognosis of Patients with Renal Cell Carcinoma and in Renal Tumor Cells Growth and Metastasis

par Huang, Xu-Qiong, Hao, Shuai, Zhou, Zi-Qi, Huang, Bin, Fang, Jia-Ying, Tang, Yan, Zhang, Jian-Hua, Xia, Jian-Chuan
Publié dans Onco Targets Ther (2020)

The changes of CD4+CD25+/CD4+ proportion in spleen of tumor-bearing BALB/c mice

par Liu, Ji-Yan, Zhang, Xiao-Shi, Ding, Ya, Peng, Rui-Qing, Cheng, Xia, Zhang, Nian-Hua, Xia, Jian-Chuan, Zeng, Yi-Xin
Publié 2005

Decreased expression of Neurensin-2 correlates with poor prognosis in hepatocellular carcinoma

par Ma, Hai-Qing, Liang, Xiao-Ting, Zhao, Jing-Jing, Wang, Hui, Sun, Jian-Cong, Chen, Yi-Bing, Pan, Ke, Xia, Jian-Chuan
Publié 2009

Overexpression of SMOC2 Attenuates the Tumorigenicity of Hepatocellular Carcinoma Cells and Is Associated With a Positive Postoperative Prognosis in Human Hepatocellular Carcinoma

par Huang, Xu-Qiong, Zhou, Zi-Qi, Zhang, Xiao-Fei, Chen, Chang-Long, Tang, Yan, Zhu, Qian, Zhang, Jian-Hua, Xia, Jian-Chuan
Publié dans J Cancer (2017)

Effect of anti-asthma Chinese medicine Chuankezhi on the anti-tumor activity of cytokine-induced killer cells

par Zhao, Jing-Jing, Pan, Ke, Wang, Qi-Jing, Xu, Zheng-Di, Weng, De-Sheng, Li, Jian-Jun, Li, Yong-Qiang, Xia, Jian-Chuan
Publié 2013

Characterization of a Novel Transgenic Mouse Tumor Model for Targeting HER2+ Cancer Stem Cells

par Wang, Su He, Lu, Lin, Fan, Yongyi, Wicha, Max S., Cao, Zhengyi, Chang, Alfred E., Xia, Jian-chuan, Baker Jr., James R., Li, Qiao
Publié 2013

Sequential Cytokine-Induced Killer Cell Immunotherapy Enhances the Efficacy of the Gemcitabine Plus Cisplatin Chemotherapy Regimen for Metastatic Nasopharyngeal Carcinoma

par Li, Yin, Pan, Ke, Liu, Li-zhi, Li, Yong-qiang, Gu, Mo-fa, Zhang, Hua, Shen, Wei-xi, Xia, Jian-chuan, Li, Jian-jun
Publié dans PLoS One (2015)

PD-L1 expression is a predictive biomarker for CIK cell-based immunotherapy in postoperative patients with breast cancer

par Zhou, Zi-Qi, Zhao, Jing-Jing, Pan, Qiu-Zhong, Chen, Chang-Long, Liu, Yuan, Tang, Yan, Zhu, Qian, Weng, De-Sheng, Xia, Jian-Chuan
Publié dans J Immunother Cancer (2019)

High expression level of EDIL3 in HCC predicts poor prognosis of HCC patients

par Sun, Jian-Cong, Liang, Xiao-Ting, Pan, Ke, Wang, Hui, Zhao, Jing-Jing, Li, Jian-Jun, Ma, Hai-Qing, Chen, Yi-Bing, Xia, Jian-Chuan
Publié 2010

Prognostic value of soluble MICA levels in the serum of patients with advanced hepatocellular carcinoma

par Li, Jian-Jun, Pan, Ke, Gu, Mo-Fa, Chen, Min-Shan, Zhao, Jing-Jing, Wang, Hui, Liang, Xiao-Ting, Sun, Jian-Cong, Xia, Jian-Chuan
Publié 2013

Immunization-based scores as independent prognostic predictors in soft tissue sarcoma patients

par Jiang, Shan-Shan, Jiang, Long, Weng, De-Sheng, Li, Yuan-fang, Pan, Qiu-Zhong, Zhao, Jing-Jing, Tang, Yan, Zhou, Zhi-Wei, Xia, Jian-Chuan
Publié dans J Cancer (2017)

Retrospective analysis of the efficacy of adjuvant CIK cell therapy in epithelial ovarian cancer patients who received postoperative chemotherapy

par Zhou, Yun, Chen, Chang-long, Jiang, Sen-wei, Feng, Yanling, Yuan, Linjing, Chen, Ping, Zhang, Lan, Huang, Shuting, Li, Jundong, Xia, Jian-Chuan, Zheng, Min
Publié dans Oncoimmunology (2018)

Tumor cells PD-L1 expression as a favorable prognosis factor in nasopharyngeal carcinoma patients with pre-existing intratumor-infiltrating lymphocytes

par Zhu, Qian, Cai, Mu-Yan, Chen, Chang-Long, Hu, Hao, Lin, Huan-Xin, Li, Min, Weng, De-Sheng, Zhao, Jing-Jing, Guo, Ling, Xia, Jian-Chuan
Publié dans Oncoimmunology (2017)

Orchestration of immune checkpoints in tumor immune contexture and their prognostic significance in esophageal squamous cell carcinoma

par Zhao, Jing-Jing, Zhou, Zi-Qi, Wang, Peng, Chen, Chang-Long, Liu, Yuan, Pan, Qiu-Zhong, Zhu, Qian, Tang, Yan, Weng, De-Sheng, Xia, Jian-Chuan
Publié dans Cancer Manag Res (2018)

PD-L1 expression patterns in tumour cells and their association with CD8(+) tumour infiltrating lymphocytes in clear cell renal cell carcinoma

par Zhu, Qian, Cai, Mu-Yan, Weng, De-Sheng, Zhao, Jing-Jing, Pan, Qiu-Zhong, Wang, Qi-Jing, Tang, Yan, He, Jia, Li, Min, Xia, Jian-Chuan
Publié dans J Cancer (2019)